GH Synergy 

Description

The GH Synergy Research Kit combines Ipamorelin (10mg), Thymosin Beta 4 TB-500 (10mg), and Thymosin Alpha 1 (10mg) — addressing GH axis stimulation, cellular repair and migration, and immune system modulation through three complementary, non-competing peptide pathways.

Kit Components

• Ipamorelin (10mg): Selective GHSR-1a agonist — pure GH release via ghrelin pathway without HPA axis co-stimulation. Reference tool for GH secretagogue pharmacology.
• TB-500 (10mg): Thymosin Beta 4 — G-actin dynamics, ILK/PI3K/Akt cell migration, angiogenesis, and cardiac progenitor activation.
• Thymosin Alpha 1 (10mg): T-cell maturation, dendritic cell activation via TLR2/TLR9, NK cell cytotoxicity, and MHC class I upregulation.

Research Context

The three thymosin proteins in this kit — Ipamorelin (acting on the GH axis) alongside Thymosin Beta 4 and Thymosin Alpha 1 — provide a broad systems biology approach to studying peptide-driven adaptive responses. Thymosin Alpha 1 provides the immune modulation context within which TB-500’s repair and Ipamorelin’s metabolic effects operate, enabling researchers to study immune-supported repair and metabolic adaptation simultaneously.

Common Research Applications

• GH axis + immune modulation + cellular repair combination studies
• Thymosin peptide family interaction research
• Multi-system biology protocols (GH/immune/repair)
• Immune-contextualized tissue repair investigation

For Research Use Only. Not for human or veterinary use.